Citadel Investment Advisory, Inc. Enovis Corp Transaction History
Citadel Investment Advisory, Inc.
- $184 Million
- Q3 2024
A detailed history of Citadel Investment Advisory, Inc. transactions in Enovis Corp stock. As of the latest transaction made, Citadel Investment Advisory, Inc. holds 3,197 shares of ENOV stock, worth $140,508. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,197
Previous 3,594
11.05%
Holding current value
$140,508
Previous $162,000
15.43%
% of portfolio
0.07%
Previous 0.09%
Shares
9 transactions
Others Institutions Holding ENOV
# of Institutions
310Shares Held
60.2MCall Options Held
1.68MPut Options Held
693K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.63MShares$292 Million0.17% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$239 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$238 Million0.0% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$132 Million0.54% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.99MShares$131 Million0.03% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.38B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...